The Food and Drug Administration (FDA) has approved the first nasal spray flu vaccine which can be administered by the patient or a caregiver. FluMist, produced by European pharmaceutical company and Covid vaccine-maker AstraZeneca, was announced last week and can be used by adults aged 49 and under.

A nasal spray flu vaccine for people up to 49 will be available for home use starting in the fall of 2025 after the Food and Drug Administration expanded its approval of AstraZeneca's FluMist. Why it matters: It will be the first flu vaccine that doesn't need to be administered by a health provider and will be sold direct to consumers for home use via an online pharmacy.

AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle. | The FDA signed off on AstraZeneca's influenza vaccine FluMist for self-administration by adults up to 49 years old and for administration by a parent or caregiver in kids between the ages of 2 and 17.

There’s good news for those who are short on time when it comes to getting a flu shot. The FDA has approved the first self-administered flu vaccine that can be taken right at home.

The US Food and Drug Administration on Friday approved the first flu vaccine that does not have to be administered by a health care provider, but it won’t be available in time for this respiratory virus season.

I love being able to go to the pharmacy for my own (or my kids’) flu shots. Pop in, get the shot, then go about my day. That process is about to get even easier: the FDA has approved the first flu vaccine that you can administer yourself,

People could previously get the nasal spray flu vaccine, called FluMist, from a health care provider, but now they can administer it themselves.

The U.S. Food and Drug Administration has approved the first at-home flu vaccine that people can self-administer.